Charles River Laboratories
676 hedge funds and large institutions have $14.1B invested in Charles River Laboratories in 2024 Q1 according to their latest regulatory filings, with 92 funds opening new positions, 257 increasing their positions, 229 reducing their positions, and 46 closing their positions.
100% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 46
88% more funds holding in top 10
Funds holding in top 10: 8 → 15 (+7)
14% more capital invested
Capital invested by funds: $12.4B → $14.1B (+$1.75B)
12% more repeat investments, than reductions
Existing positions increased: 257 | Existing positions reduced: 229
7% more funds holding
Funds holding: 633 → 676 (+43)
0.47% less ownership
Funds ownership: 102.25% → 101.79% (-0.47%)
47% less call options, than puts
Call options by funds: $52M | Put options by funds: $98.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$158M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$61.9M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$57M |
| 4 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
+$41.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$36.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$122M |
| 2 |
TGA
TPG GP A
Fort Worth,
Texas
|
-$101M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$87.2M |
| 4 |
SCA
Southpoint Capital Advisors
New York
|
-$71.6M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$63.4M |
CRL Hedge Fund Activity: Q1 2024 in Review
676 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2024, worth a combined $14.1B — up 14% from $12.4B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new CRL positions and 46 closed out — a net gain of 46 holders — while 257 added to existing stakes and 229 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $158M. The largest seller was Morgan Stanley, cutting an estimated $122M.
- 676 institutional investors held Charles River Laboratories (CRL) as of Q1 2024, up from 633 in Q4 2023.
- Funds reported $14.1B of Charles River Laboratories stock for Q1 2024, up 14% quarter-over-quarter.
- 92 funds opened new Charles River Laboratories positions in Q1 2024 and 46 closed out, a net change of +46 holders.
- The largest Charles River Laboratories buyer in Q1 2024 was Marshall Wace, an estimated $158M added.
- The largest Charles River Laboratories seller in Q1 2024 was Morgan Stanley, an estimated $122M sold.
Based on aggregated 13F filings for Q1 2024.